Trials / Completed
CompletedNCT02529865
Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence
Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Nagoya University · Academic / Other
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of periurethral injection of autologous Adipose Derived Regenerative Cells (ADRCs) in male stress urinary incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Periurethral injection of autologous ADRCs and adipose tissue | 1 mL of the isolated ADRC is injected into the region of the external urethral sphincter, and another 4 mL of the ADRC and 16mL autologous adipose cells is injected under the urethral mucosa. |
Timeline
- Start date
- 2015-07-29
- Primary completion
- 2019-03-07
- Completion
- 2019-03-07
- First posted
- 2015-08-20
- Last updated
- 2019-11-14
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02529865. Inclusion in this directory is not an endorsement.